Kevin 
Aniskovich

CEO

Kevin Aniskovich is the Chief Executive Officer of Itiliti Health, Inc., where he leads the company’s mission to reduce the cost of care by modernizing prior authorization for payers. A healthcare CEO and serial entrepreneur with 30 years of experience, Kevin has built his career identifying market opportunities in complex, regulated markets, building companies around the solutions to address them, and delivering successful exits.

 

Most recently, Kevin served as President & CEO of Jumo Health, where he led the company’s transformation from a pediatric disease education publisher into a global medical communications platform serving the pharmaceutical industry. Under his leadership, Jumo Health scaled across four continents—delivering services in more than 90 languages in over 75 countries—and built partnerships with more than 50 life sciences companies, including most of the top 25 global pharmaceutical firms. The company was named to the Inc. 5000 list of America’s fastest-growing private companies three consecutive years before its sale to Falfurrias Capital Partners in 2024.

 

Kevin’s entrepreneurial journey in healthcare began with founding Intelecare Compliance Solutions, a technology company focused on medication adherence. He built the industry’s first platform to integrate mail-order pharmacy services within mobile and web-based solutions, scaling it to more than 12 million users before its acquisition by Remedy Health Media. He went on to serve as Chief Innovation Officer at both Remedy Health Media as part of the acquisition and then Sharecare. Previously Kevin was part of the original sales organization at Epocrates, the market leader in clinical decision support tools.

 

Kevin’s commitment to healthcare is personal following his mother’s diagnosis with a rare disease, he dedicated his career to finding novel ways to help patients access the information and tools needed to improve their care. He currently serves on the board of the International Children’s Advisory Network (iCAN), and was named one of PharmaVoice Magazine’s Top 100 Most Inspiring People in Life Sciences.